Omeprazole is used to treat similar conditions ... Brand-name versions include Pepcid, Pepcid AC, and Zantac 360. The Food ...

After 6 months, omeprazole 20 mg/day was found to be more effective than ranitidine. More omeprazole recipients stopped treatment because of adverse events (6.1 vs 3.2%) but otherwise rates of ...

Famotidine (Pepcid) and omeprazole (Prilosec) are popular effective treatment ... Brand-name versions include Pepcid, Pepcid AC, and Zantac 360. The Food and Drug Administration (FDA) has approved OTC ...

j LOS = length of hospital stay. 39 d 92 Omeprazole 40 mg orally daily or ranitidine 50 mg i.v. every 6 hr Rebleeding: 0% vs. 17% LOS: 3.9 days vs. 6.4 days e 40 100 Omeprazole 40 mg i.v. once ...

Aims—To determine the effects of ranitidine, famotidine, and omeprazole on gastric motility and emptying. Patients and methods—Fifteen normal subjects underwent simultaneous antroduodenal manometry, ...

GSK to pay $70 million to settle whistleblower lawsuit Pfizer and Sanofi also settling Zantac cases Boehringer Ingelheim faces trial, denies wrongdoing Oct 9 (Reuters) - GSK (GSK.L), opens new tab ...

British pharmaceutical company GSK said Wednesday it has agreed to pay $2.3 billion in the United States to put an end to lawsuits alleging that its Zantac heartburn drug caused cancer. "GSK today ...

GSK has agreed to pay up to $2.2 billion to resolve approximately 80,000 lawsuits brought by users of Zantac who claimed the heartburn drug caused their cancer. The agreement frees the British ...

GSK Plc said it will pay as much as $2.2 billion to resolve about 80,000 US court cases related to allegations that its old reflux medication Zantac was contaminated with a suspected carcinogen.

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on ...